Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics
LOUISVILLE, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leader in personalized diagnostics, announced that the company is designated as a Thermo Fisher Scientific Center of Excellence (COE) as part of Thermo Fisher's collaborative initiative to advance NGS-based diagnostics. The services provided to Thermo Fisher are an example of Biodesix Development Services offerings, including customizable options that enable the world's leading life sciences companies, biopharmaceutical, and medical research institutions with scientific, technological, and operational capabilities.
As Thermo Fisher announced in July 2025, Biodesix was an instrumental partner in the validation of the Oncomine Dx Express Test leading to the FDA approval of the Genexus Dx Integrated Sequencer. Biodesix Development Services conducted validation studies utilizing its design-controlled laboratory processes, quality management systems, and contributed data generation in support of regulatory submission.
'Working with Thermo Fisher, we continue to forge a path to conquer cancer, and we are delighted to expand our molecular diagnostic and NGS testing capabilities in tissue-based profiling,' said Scott Hutton, CEO at Biodesix. "Being a member of Thermo Fisher's COE network puts us in excellent company with other global groups committed to transforming cancer diagnosis and care. We are excited about the potential to offer the Oncomine Dx Express Test in the future.'
Upcoming presentations to learn more about the Thermo Fisher NGS precision oncology solution and how Biodesix will apply the science for its industry clients and healthcare professionals:
August 27, 2025 | CAP TODAY | Thermo Fisher Scientific Webinar: Introduction of new FDA approved rapid NGS solution for Companion Diagnostics & tumor profiling in oncology. Speakers: David Chi, PhD, Thermo Fisher Scientific, Bence Sipos, MD, and Gary Pestano, PhD, Chief Development Officer, Biodesix
September 15, 2025 | Orlando, FL | College of American Pathologists (CAP) 2025 Annual Meeting | Thermo Fisher-sponsored Panel: "Introduction of new IVD solution for rapid NGS profiling in Oncology". Speakers: Mahmoud Elsayad, MD, FCAP, University of Texas Health, Alison Roos, Thermo Fisher Scientific, and Gary Pestano, PhD, Chief Development Officer, Biodesix
About Biodesix:Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests, marketed as Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world's leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. For more information, visit biodesix.com.
About the Thermo Fisher COE Network: Thermo Fisher's NGS COE Network partners with leading global institutions to develop, validate, and refine its Ion Torrent™ Oncomine™ solutions portfolio. Through these COEs, Thermo Fisher collaborates with experts to accelerate oncology research, foster strategic alliances, and advance precision medicine.
Biodesix Contacts:
Media:Natalie St. Denis, Director Corporate Communications, Biodesixnatalie.stdenis@biodesix.com(720) 925-9285
Investors:Chris Brinzey, Partner, ICRchris.brinzey@icrhealthcare.com(339) 970-2843
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Jerome Powell Set To Deliver Pivotal Jackson Hole Address As Analysts Warn It Could Be 'Make-Or-Break' Moment For Dovish Fed
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Federal Reserve Chair Jerome Powell's upcoming speech at the Jackson Hole Economic Policy Symposium on Friday is being billed as a pivotal, "make-or-break" moment for the central bank's more dovish contingent. This annual gathering of central bankers, economists, and financial leaders in Wyoming is one of the most closely watched events on the economic calendar, and this year's address is no exception. Market Experts Are Widely Anticipating A "Conciliatory" Tone The anticipation surrounding Powell's speech has been fueled by a growing consensus among market analysts that the Fed is poised to ease its monetary policy. Trending: The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — According to Gary Black of The Future Fund, money markets are now pricing in an 84% chance of a 25-basis-point rate cut in September, with expectations for two cuts by the end of the year. He says that Powell's speech 'could be make-or-break moment for a more dovish Fed.'This sentiment persists despite a recent hotter-than-expected Producer Price Index (PPI) report for July. Similarly, Tom Lee of FundStrat has expressed his hope for a 'conciliatory tone to rate cuts' from the Fed Chair. Historical Market Reaction To Jackson Hole Historically, the S&P 500's performance in the week following the Jackson Hole symposium has been mixed, often marked by increased volatility as investors digest the Federal Reserve's messaging. According to analysis from Kevin Gordon of Schwab, citing Bloomberg Intelligence data, the index has gained an average of 0.4% in the week after the event since 2000.2025 Theme To Highlight Transitions In Labor Markets The theme for the 2025 symposium, which will take place from Aug. 21-23, is 'Labor Markets in Transition: Demographics, Productivity, and Macroeconomic Policy.' This theme will guide the discussions and papers presented at the event, with a focus on how shifts in the labor market will impact the broader economy and monetary policy decisions. As the world watches, Powell's speech against this backdrop will be scrutinized for any hints about the future direction of the U.S. economy and the Fed's response to the evolving landscape. The Jackson Hole symposium, hosted by the Federal Reserve Bank of Kansas City, has a long history of being a platform for major policy announcements. The event brings together a select group of around 120 attendees, including central bankers from around the world, academics, and government officials, to discuss pressing long-term economic issues. Read Next: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.30/share. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Image Credit: Jack Gruber-USA TODAY via Imagn This article Jerome Powell Set To Deliver Pivotal Jackson Hole Address As Analysts Warn It Could Be 'Make-Or-Break' Moment For Dovish Fed originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Equities Mostly Fall Intraday as Tech, Communication Services Sectors Weigh
US benchmark equity indexes were mostly lower intraday, weighed down by declines in the technology a Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Dr. Phil's Distribution Partner Sues for Fraud, Breach of Contract Over $500 Million, 10-Year Deal
The talk show host's Merit Street Media is simultaneously suing Trinity Broadcasting while facing off in bankruptcy court Trinity Broadcasting is countersuing Dr. Phil McGraw's Merit Street Media in bankruptcy court for fraud and breach of contract. In a complaint filed Tuesday in U.S. Bankruptcy Court for the Northern District of Texas and obtained by TheWrap, Trinity Broadcasting, McGraw's distribution parter, alleges that he defrauded the Christian television network through a $500 million, 10-year distribution agreement—claiming he failed to deliver even a single episode of his new talk show. More from TheWrap How to Watch 'South Park' Season 27: When Is Episode 3 Streaming? Francis Ford Coppola's 'Megalopolis' Reborn: See Pages From the New Graphic Novel | Exclusive 'Sekiro: Shadows Die Twice' Video Game Gets Anime Adaptation at Crunchyroll Dr. Phil's Distribution Partner Sues for Fraud, Breach of Contract Over $500 Million, 10-Year Deal On the other hand, Merit Street (which is currently in bankruptcy court) argues that Trinity Broadcasting failed to uphold its end of their joint venture, primarily by not securing national distribution. Instead, the network abused 'its power as a controlling shareholder,' the company claims, by pressuring Merit Street into costly third-party distribution deals rather than using Trinity's existing network of local TV stations. While Merit's suit alleges 'shoddy production services' from TBN, the 'most egregious' issue, it says, is that Merit Street programs could not be seen nationwide due to 'withholding distribution payments despite repeatedlyacknowledging those distribution payments were 100% TBN's sole responsibility.' 'Simply put, as a result of TBN's conduct, Merit Street has nowhere to send its broadcast signal and nowhere to air its programming,' Merit's suit alleges. Trinity tells a different story. In its countersuit, the broadcaster says McGraw himself approached the company in 2022 after seeking a replacement for CBS as both production and distribution partner for his talk show. Trinity contends McGraw made key assurances about the show's financial health and continued popularity that ultimately proved misleading. The lawsuit alleges these assurances included McGraw's proposed cost-cutting measures: a 40 percent reduction in the show's $68 million annual production budget by relocating all operations to Texas from California and eliminating unionized staff. He also asserted ownership of the series, claiming CBS had already sold out its advertising inventory, and promised to deliver new, expanded 90-minute episodes. Through his production company, Peteski, McGraw allegedly told Trinity Broadcasting that it had to sign a deal with Peteski and pay him $20 million upfront as a show of good faith—or he would instead accept CBS' competing offer of $75 million per year. Anything less, he warned, would be a 'deal killer,' according to the lawsuit. According to the complaint, under a purported $500 million, ten-year agreement, Trinity Broadcasting was to provide production and distribution services to Merit Street, while Peteski would supply new content, including 160 episodes. 'TBN is confident that the truth will set it free, and result in Peteski and McGraw being held accountable for their reprehensible conduct,' the lawsuit reads. The partnership reportedly deteriorated last year when McGraw allegedly failed to deliver the promised viewership, product integrations, and advertising revenue to Trinity Broadcasting. The network claims it had spent over $100 million by the end of June (some of which was recorded as loans to Merit Street). The lawsuit states that amount continued to climb as Trinity Broadcasting funneled up to $13 million per month into production, even though McGraw had yet to produce a single episode. When Trinity Broadcasting stopped its payments, McGraw accused the network of breaching the contract and subsequently filed for bankruptcy. Trinity Broadcasting asserts multiple claims of fraud and breach of contract, seeking a court determination of both companies' rights and obligations under the agreement. It also asks the court to rule that McGraw had agreed to transfer his library of Dr. Phil episodes. McGraw's lawsuit requests Merit Street be awarded damages on all counts, legal fees, and 'such other and further relief as the Court may deem just and proper,' though no specific amount for such was listed. McGraw's media venture was founded just last year, after his 'Dr. Phil' TV show ended with the 2022-23 season. Merit Street Media did not immediately return TheWrap's request for comment. The post Dr. Phil's Distribution Partner Sues for Fraud, Breach of Contract Over $500 Million, 10-Year Deal appeared first on TheWrap.
